Europe, Middle East & Africa
Trials built for the age of innovation
Personalized medicine offers tremendous hope for patients. This change in focus to specialty treatments for highly defined patient populations also requires a change in how research works, customized just as specifically as the treatments it is designed to test.
57 orphan drugs
Number of drugs with orphan indications approved in the U.S. between January and August 201815 oncology drugs
The number of new oncology therapeutics launched in 2018$452 billion
Projected value of the biologics market in 202230% improvement
in non-enrolling sites with CORE-powered studies
Powering change with the IQVIA CORE
IQVIA combines deep therapeutic and scientific knowledge with unmatched experience in clinical trial design and execution. Using the IQVIA CORE we can integrate data, analytics, and technology around the specific requirements of your trial. So we can anticipated challenges, ask the right questions and help you
- Reach milestones faster: From identifying trial sites that are likely to succeed, to recruiting the right patients
- Be more precise: From choosing indications, to comparing scenarios and analyzing key metrics to drive better decisions
- Leverage the expertise you need: From artificial intelligence and machine learning, to experts in local markets around the world
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Access central labs around the globe through Q² Solutions, a joint venture between IQVIA and Quest Diagnostics.
30% improvement
in non-enrolling sites with CORE-powered studiesDecrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Bring trials directly to patients to decrease costs, increase quality and improve access.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.